Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2005.01028.x/fullpdf
Reference15 articles.
1. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report;Hoofnagle;N Engl J Med,1986
2. Interferon therapy reduces the risk for hepatocellular carcinoma;Yoshida;national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan,1999
3. Risk factor for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group;Kasahara;Hepatology,1998
4. The effect of treatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C;Toyoda;Cancer,2000
5. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis;Nishiguchi;Lancet,1995
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The changing scenario of hepatocellular carcinoma in Italy: an update;Liver International;2020-12-02
2. Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?;International Journal of Molecular Sciences;2020-02-28
3. Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability;Clinical Science;2016-10-20
4. Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan;Journal of Medical Economics;2015-03-31
5. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits;BMC Infectious Diseases;2015-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3